Concourse Financial Group Securities’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10391 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10668 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10571 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10307 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10073 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9840 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9594 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9374 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9015 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9024 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8830 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8666 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8468 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8187 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7770 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7409 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7092 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6814 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6570 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6408 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6303 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6216 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6061 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6054 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5936 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5850 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5695 |
|